The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

Wed, 01st Nov 2023 08:50

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

The FTSE 100 index opened up 10.87 points, 0.2%, at 7,332.59. The FTSE 250 was down 12.42 points, 0.1%, at 17,070.63, and the AIM All-Share was up 1.13 points, 0.2%, at 680.98.

The Cboe UK 100 was up 0.2% at 731.19, the Cboe UK 250 was down 0.1% at 14,837.88, and the Cboe Small Companies was slightly lower at 12,589.71.

In European equities, the CAC 40 in Paris was up 0.4%, while the DAX 40 in Frankfurt was up 0.3%.

With the Israel-Hamas war seeming to remain fairly contained for now, investors' focus was locked on the upcoming interest rate decision from the US.

The Federal Reserve is widely anticipated to leave interest rates where they are at its November meeting, and will be hoping that the recent rise in bond yields will help to do some of the heavy lifting. The decision will be announced at 1800 GMT.

"Accompanying comments will inevitably be scrutinised for the Fed’s latest thinking on where to move from here, and with the US economy still showing few signs of weakening, the case remains for a tight monetary environment to prevail for the time being," said interactive investor's Richard Hunter.

Sterling was quoted at USD1.2152 early Wednesday, higher than USD1.2128 at the London equities close on Tuesday. The euro traded at USD1.0563, little changed from USD1.0562.

In early local economic news, the annual pace of decline in UK house prices eased somewhat in October, according to Nationwide data on Wednesday, as prices rose on a monthly basis.

On a seasonally-adjusted basis, UK house prices rose 0.9% in October from September, compared to the 0.1% rise in September from August.

On an annual basis, prices were 3.3% lower in October, slowing from the 5.3% decline seen in September.

"The data... may on the face of it, appear to show the housing market is in better shape, but it is more indicative of homeowners staying put rather than swallowing sharply higher borrowing costs," noted Hargreaves Lansdown's Susannah Street.

The Bank of England will announce its interest rate decision on Thursday, with the market anticipating it will hold interest rates once again.

In the FTSE 100, GSK rose 1.7% as it upgraded its annual guidance, after a strong third quarter.

For 2023, the pharmaceutical firm now expects turnover to grow between 12% and 13%, compared to a prior range of 8% to 10%. Adjusted operating profit is now forecast to rise between 13% and 15%, compared to 11% to 13% before. The figures refer to constant exchange rate growth and exclude Covid-19 solutions. In the third quarter, turnover rose to GBP8.15 billion from GBP7.83 billion a year before. Pretax profit was GBP1.79 billion, rising sharply from GBP1.01 billion. It declared a third-quarter dividend of 14 pence, and expects 56.5p for the whole year.

"Competitive performance was broadly based but benefitted particularly from the outstanding US launch of Arexvy, the world's first RSV vaccine," said CEO Emma Walmsley.

Next rose 1.6% as it upped its annual pretax profit guidance by GBP10 million to GBP885 million, as full price sales in the third quarter came in ahead of guidance.

The retailer said full price sales in the period from August to October grew 4.0% annually, ahead of guidance of 2.0%. For the financial year as a whole, it expects full price sales to grow 3.1% to GBP4.74 billion, assuming they see 2.0% growth in the remainder of the year. However, it noted sales growth has been variable in recent months, which it attributes to changing weather conditions as opposed to underlying changes in the consumer economy.

At the other end of the FTSE 100 were Segro down 3.1%, as Goldman Sachs cut the stock to 'sell'. BP fell 1.1%, as JPMorgan cut the stock to 'underweight' from 'neutral', after its third-quarter results missed profit estimates on Tuesday.

In the FTSE 250, Aston Martin Lagonda Global dropped 10%.

The luxury sports car manufacturer said third-quarter revenue rose 15% to GBP362.1 million year-on-year from GBP315.5 million, and pretax loss narrowed to GBP117.6 million from GBP225.9 million. It left most of its guidance for 2023 unchanged, but trimmed wholesales volumes guidance to around 6,700 units from previous guidance of around 7,000 units.

Against the yen, the dollar was quoted at JPY151.33, down versus JPY151.63.

The yen found some strength after Japan's top currency official said that Tokyo was "on standby" to intervene after the yen fell to a new year-low against the dollar and plunged against the euro, Bloomberg reported.

"We're on standby," currency official Masato Kanda told reporters, according to Bloomberg News. "But I can't say what we'll do, and when – we'll make judgements overall, and we're making judgements in a state of urgency."

In Japan on Wednesday, the Nikkei 225 index in Tokyo was closed up 2.4%. Toyota closed up 4.7%, as the carmaker increased its annual profit forecast, crediting cost-cutting efforts and the weaker yen.

In China, the Shanghai Composite closed up 0.1%, while the Hang Seng index in Hong Kong closed marginally lower.

Chinese manufacturing returned to a mild state of contraction in October, survey data revealed. The Caixin manufacturing purchasing managers' index fell to 49.5 points in the month from 50.6 in September. Falling below the 50-point no-change mark, it shows activity fell in the sector.

The S&P/ASX 200 in Sydney closed up 0.9%.

In the US on Tuesday, Wall Street ended higher, with the Dow Jones Industrial Average down 0.4%, the S&P 500 up 0.7% and the Nasdaq Composite up 0.5%.

Gold was quoted at USD1,976.94 an ounce early Wednesday, lower than USD1,989.19 on Tuesday.

Brent oil was trading at USD85.55 a barrel, down from USD86.09.

Wednesday's global economic calendar has further manufacturing PMIs from the UK and the US.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.